CONSEIL DE L. EUROPE EDQM CONSEIL

EDQM (European Directorate for the Quality of Medicines & HealthCare) is not a company, factory, or trading company based in Malaysia. It is an international organization under the Council of Europe, headquartered in Strasbourg, France.

Therefore, it cannot be classified as a factory or a trading company in Malaysia.

Company Introduction:

The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a leading organization that protects public health by enabling the development, use, and safe application of high-quality medicines and promoting ethical practices in blood transfusion and organ donation. It establishes and provides official standards for the quality of medicines and their components through the European Pharmacopoeia. The EDQM also offers certification of suitability to the monographs of the European Pharmacopoeia (CEP), which assesses the chemical purity of active pharmaceutical ingredients. Additionally, it coordinates a network of Official Medicines Control Laboratories (OMCLs) and develops guidelines in areas such as blood transfusion, organ transplantation, and consumer health. Its primary role is regulatory and standard-setting, not manufacturing or trading commercial products.

The entity "CONSEIL DE L. EUROPE EDQM CONSEIL" is not a commercial company that manufactures or sells products in Malaysia in the traditional sense. It appears to be a misinterpretation of the European Directorate for the Quality of Medicines & HealthCare (EDQM), which is part of the Council of Europe (Conseil de l'Europe).

The EDQM is an international organization responsible for public health initiatives. It does not produce or sell consumer goods or pharmaceutical products directly. Instead, its primary functions and "offerings" that are utilized globally, including by pharmaceutical companies in Malaysia, are:

1. European Pharmacopoeia (Ph. Eur.)

Description: A comprehensive collection of monographs that describe the quality standards for active substances, excipients, and medicinal products. Pharmaceutical manufacturers in Malaysia, like those worldwide, refer to and comply with these standards for the quality control of their own products.

2. European Pharmacopoeia Reference Standards

Description: Physical reference materials (chemical reference substances, biological reference preparations, herbal reference standards, etc.) that are essential for performing the tests and assays described in the European Pharmacopoeia monographs. Malaysian pharmaceutical companies purchase and use these reference standards for their internal quality control and testing processes.

3. Certificates of Suitability to the European Pharmacopoeia (CEPs)

Description: Certificates issued by the EDQM that attest that the quality of a substance (primarily active pharmaceutical ingredients and excipients) is suitably controlled by the relevant European Pharmacopoeia monograph. Pharmaceutical companies in Malaysia that import or use these substances in their manufacturing processes often require suppliers to have a valid CEP to ensure compliance with quality standards.

4. Publications and Databases

Description: Various publications, guides, and databases related to good manufacturing practices (GMP), quality control, and regulatory affairs in the pharmaceutical sector. These resources provide guidance and information for regulatory bodies and pharmaceutical manufacturers in Malaysia.

In summary, while the EDQM does not "sell products" in Malaysia, its standards, reference materials, and certifications are integral to the quality assurance and regulatory compliance framework for the pharmaceutical industry in Malaysia and globally.